caa a22 4500 477098355 CHVBK 20180405111534.0 cr unu---uuuuu 170330e19960201xx s 000 0 eng 10.1007/BF02625947 doi (NATIONALLICENCE)springer-10.1007/BF02625947 Peritoneal carcinomatosis from appendiceal cancer: A paradigm for treatment of abdomino-pelvic dissemination of gastrointestinal malignancy [Elektronische Daten] [P. Sugarbaker, D. Chang, Patricia Koslowe] Peritoneale Karzinomatose bei Appendixkarzinom: ein Paradigma für die Behandlung von Magen- und Kolonkarzinom und deren Verbreitung in der Bauchhöhle Summary: Background: Peritoneal carcinomatosis from appendix cancer is a rare disease which has generally not been studied. 104 patients treated by a uniform treatment strategy have been followed for up to 10 years. Methods: The clinical features that correlate with improved survival included low vs. high histologic grade, complete vs. incomplete cytoreduction, lymph nodes negative rather than positive for metastasis and minimal vs. extensive prior surgery. By the Cox semi-parametric model the independent variables were histologic grade and completeness of cytoreduction. From these data prognostic groups 1, 2 and 3 were formulated. Results: Patients in prognostic group 1 had a complete cytoreduction and a grade 1 histopathology with a 5 year survival of 90%. Patients in prognostic group 2 had a complete cytoreduction with grade 2 or 3 histopathology and a 70% 5 year survival. Patients in group 3 had an incomplete cytoreduction, and a 5 year survival of 22%. Conclusions: These data accumulated on patients with appendix cancer may have relevance to the management of patients with peritoneal carcinomatosis from other gastrointestinal cancers. Blackwell Science Ltd, 1996 Appendix cancer nationallicence Intraperitoneal chemotherapy nationallicence pseudomyxoma peritonei nationallicence cytoreduction nationallicence Appendixkarzinom nationallicence intraperitoneale Chemotherapie nationallicence Pseudomyxoma peritonei nationallicence Zytoreduktion nationallicence Sugarbaker P. Washington Cancer Institute, 110 Irving Street, N.W., 20010, Washington D.C. aut Chang D. Washington Cancer Institute, 110 Irving Street, N.W., 20010, Washington D.C. aut Koslowe Patricia Washington Cancer Institute, 110 Irving Street, N.W., 20010, Washington D.C. aut Acta Chirurgica Austriaca Springer-Verlag 28/1(1996-02-01), 4-8 0001-544X 28:1<4 1996 28 10353 https://doi.org/10.1007/BF02625947 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF02625947 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Sugarbaker P. Washington Cancer Institute, 110 Irving Street, N.W., 20010, Washington D.C aut NATIONALLICENCE 700 1- Chang D. Washington Cancer Institute, 110 Irving Street, N.W., 20010, Washington D.C aut NATIONALLICENCE 700 1- Koslowe Patricia Washington Cancer Institute, 110 Irving Street, N.W., 20010, Washington D.C aut NATIONALLICENCE 773 0- Acta Chirurgica Austriaca Springer-Verlag 28/1(1996-02-01), 4-8 0001-544X 28:1<4 1996 28 10353 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer